Pubfacts - Scientific Publication Data
  • Categories
  • |
  • Journals
  • |
  • Authors
  • Login
  • Categories
  • Journals

Search Our Scientific Publications & Authors

Publications
  • Publications
  • Authors
find publications by category +
Translate page:

Increasing Incidence and Declining Mortality After Cancer-Associated Venous Thromboembolism: Nationwide Cohort Study.

Authors:
Anne Gulbech Ording Flemming Skjøth Mette Søgaard Anette Arbjerg Højen Thure Filskov Overvad Simon Noble Samuel Zachary Goldhaber Torben Bjerregaard Larsen

Am J Med 2021 Feb 22. Epub 2021 Feb 22.

Unit for Thrombosis and Drug Research, Department of Cardiology; Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Faculty of Medicine, Aalborg University, Aalborg, Denmark.

Purpose: The incidence of cancer-associated venous thromboembolism has increased, but whether short-term mortality after cancer-associated venous thromboembolism has changed remains uncertain. We investigated whether the increasing incidence of venous thromboembolism in cancer patients is associated with a change in mortality.

Methods: We used administrative medical registries to identify a cohort of all Danish patients diagnosed with a first primary cancer from 2006 to 2017. We examined temporal changes in 1-year risks of venous thromboembolism and in mortality risks at 30 days and 1 year after venous thromboembolism. Cox regression was used to assess changes in mortality rate ratios over time.

Results: We included 350,272 cancer patients (median age 68 years, 49.1% female), of whom 8167 developed venous thromboembolism within 1 year after cancer diagnosis. The cumulative 1-year risk of venous thromboembolism was 1.8% in 2006-2008, increasing to 2.8% for patients diagnosed in 2015-2017. The 30-day mortality after venous thromboembolism decreased from 15.1% in 2006-2008 to 12.7% in 2015-2017, and the 1-year mortality decreased from 52.4% to 45.8%, equivalent to a hazard ratio (HR) of 0.83 (95% confidence interval [CI], 0.75-0.90). This pattern of declining 1-year mortality was consistent for patients with pulmonary embolism, HR 0.79 (95% CI, 0.69-0.90), and deep venous thrombosis, HR 0.76 (95% CI, 0.67-0.87). Lower mortality over time was evident across all strata of cancer stage, cancer type, and cancer treatment.

Conclusions: The 1-year risk of venous thromboembolism after a first primary cancer diagnosis in Denmark increased during 2006-2017. This increase was accompanied by declining mortality.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjmed.2021.01.031DOI Listing
February 2021

Publication Analysis

Top Keywords

venous thromboembolism
40
cancer-associated venous
12
venous
11
thromboembolism
10
mortality
9
primary cancer
8
patients diagnosed
8
cancer
8
1-year mortality
8
cancer patients
8
cancer diagnosis
8
mortality cancer-associated
8
risk venous
8
increasing incidence
8
declining mortality
8
1-year risk
8
1-year
5
patients
5
diagnosis cumulative
4
491% female
4

Keyword Occurance

Similar Publications

Antithrombotic Management in Ischemic Stroke with Essential Thrombocythemia: Current Evidence and Dilemmas.

Authors:
Shubhabrata Das Anasua Deb

Med Princ Pract 2021 Apr 13. Epub 2021 Apr 13.

Thrombotic diseases like ischemic stroke are common complications of essential thrombocythemia (ET) due to abnormal megakaryopoiesis and platelet dysfunction. Ischemic stroke in ET can occur as a result of both cerebral arterial and venous thrombosis. Management of ET is aimed at preventing vascular complications including thrombosis. Read More

View Article and Full-Text PDF
April 2021
Similar Publications

Impact of Weight on Anti-Xa Attainment in High-Risk Trauma Patients on Enoxaparin Chemoprophylaxis.

Authors:
Julie Elizabeth Farrar Molly Elizabeth Droege Carolyn Dosen Philpott Eric William Mueller Neil Edward Ernst Amy Teres Makley Kaley Marie Deichstetter Christopher Allen Droege

J Surg Res 2021 Apr 10;264:425-434. Epub 2021 Apr 10.

Department of Pharmacy Services, UC Health - University of Cincinnati Medical Center, Cincinnati, Ohio; University of Cincinnati James L. Winkle College of Pharmacy, Cincinnati, Ohio.

Background: Serum anti-factor Xa (anti-Xa) concentration may guide low molecular weight heparin chemoprophylaxis in trauma patients. Higher total body weight (TBW) is a risk factor for subprophylactic anti-Xa and venous thromboembolism (VTE). The purpose of this study was to evaluate TBW differences in patients with subprophylactic versus prophylactic trough anti-Xa. Read More

View Article and Full-Text PDF
April 2021
Similar Publications

Neutrophil extracellular traps induced by pro-inflammatory cytokines enhance procoagulant activity in NASH patients.

Authors:
Jingwen Du Jinming Zhang Xiaojing Chen Shuoqi Zhang Cong Zhang Huan Liu Yueyue Li Mengdi Li Xiaoming Wu Mengqi Xiang Chengyue Wang Langjiao Liu Chunli Wang Shaohong Fang Jialan Shi

Clin Res Hepatol Gastroenterol 2021 Apr 10:101697. Epub 2021 Apr 10.

Department of Hematology, The First Affiliated Hospital, Harbin Medical University, Harbin Heilongjiang, China; Department of Research, VA Boston Healthcare System, Harvard Medical School, Boston, MA, USA; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, 1400 VFW Parkway, West Roxbury, Boston, MA 02132, USA. Electronic address:

Background: Nonalcoholic steatohepatitis (NASH) patients are at a high risk of developing venous thromboembolism, with a high rate of morbidity and mortality. The role of neutrophil extracellular traps (NETs) in procoagulant activity (PCA) in patients with NASH remains unclear. Our study aimed to investigate the formation of NETs in NASH patients stimulated by specific pro-inflammatory factors. Read More

View Article and Full-Text PDF
April 2021
Similar Publications

Multiple arterial and venous thromboembolism in a male patient with hereditary protein C deficiency: A case report.

Authors:
Likun Sun Xin Li Quanming Li Lunchang Wang Jiehua Li Chang Shu

Medicine (Baltimore) 2021 Apr;100(15):e25575

Department of Vascular Surgery, The Second Xiangya Hospital of Central South University.

Rationale: Hereditary protein C deficiency has a high prevalence in Asian populations, being the important risk factor associated with thrombophilia. Traditionally, conservative medication is the first choice for patients with hereditary protein C deficiency. However, there are few reports on whether aggressive surgical treatment can be performed when patients continue to develop life-threatening ischemic symptoms after adequate anticoagulant and thrombolytic therapy. Read More

View Article and Full-Text PDF
April 2021
Similar Publications

Letter to the Editor from Blasdel et al: No Venous Thromboembolism Increase Among Transgender Female Patients Remaining on Estrogen for Gender Affirming Surgery.

Authors:
Gaines Blasdel Nabeel Shakir Augustus Parker Rachel Bluebond-Langner Lee Zhao

J Clin Endocrinol Metab 2021 Apr 13. Epub 2021 Apr 13.

Department of Urology, New York University Langone Health, New York, NY.

View Article and Full-Text PDF
April 2021
Similar Publications
© 2021 PubFacts.
  • About PubFacts
  • Privacy Policy
  • Sitemap